jobs

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Markets Biotechnology Breaking News: Europe
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health care industry Business Pharmaceuticals
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Sage Group PLC Markets Economy
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health & Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Healthy Returns Roche Holding AG
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Amazon/com Inc
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Novo Nordisk A/S Prescription drugs Health care industry
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags GE HealthCare Technologies Inc Health & Science AstraZeneca PLC
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Pharmaceuticals Weight management Business
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Exchange/traded funds Wall Street Breaking News: Markets
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags 5 Things to Know Business Abercrombie & Fitch Co
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Amgen Inc Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Health care industry Amgen Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Healthy Returns Health care industry
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Social issues Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Breaking News: Business Health & Science Business News
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Health care industry Diabetes Medical research
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags semaglutide Benzinga Food and Drug Administration
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags Health care industry Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health & Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Mad Money S&P 500 Novo Nordisk A/S
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Europe News
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags World News Business Health care industry
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Jobs Daily Open China Markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags JPMorgan Chase & Co Delta Air Lines Inc Vistra Corp
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Strikes Labor unions ICU Medical Inc
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Transportation Infrastructure Samsung Electronics Co Ltd Strikes
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News Instagram Instagram
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

922 Allowance Ave SE
Medicine Hat, AB T1A 3G7

Office hours: 8:30 a.m.-4:30 p.m. Monday to Friday, closed Saturday Sunday and statutory holidays.

[P] 403.527.1101
[F] 403-527-0737

Print Advertising: 403.528.5659
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2024 The Medicine Hat News